Download PDF
Thromb Haemost 2000; 83(03): 358-359
DOI: 10.1055/s-0037-1613819
Commentary
Schattauer GmbH

Factor V HR2: An Ancient Haplotype out of Africa – Reasons for being Interested

Elena M. Faioni
1   From the A. Bianchi Bonomi Hemophilia and Thrombosis Center, I.R.C.C.S. Maggiore Hospital and Department of Internal Medicine, University of Milano, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 1996; 75: 45-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Castoldi E, Rosing J, Girelli D, Hoekema L, Lunghi B, Mingozzi F, Ferraresi P, Friso S, Corrocher R, Tans G, Bernardi F. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma. Thromb Haemost 2000; 83: 362-5.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-7.
    PubMedSearch in Google Scholar
  • 4 Rees DC. World distribution of factor V Leiden. Lancet 1995; 346: 1133.
    CrossrefPubMedSearch in Google Scholar
  • 5 Castaman G, Lunghi B, Missiaglia E, Bernardi F, Rodeghiero F. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His 1299Arg substitutions in factor V. Br J Haematol 1997; 99: 257-61.
    CrossrefPubMedSearch in Google Scholar
  • 6 Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry M-L, Fiessinger J-N, Emmerich J, Aiach M. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999; 81: 193-7.
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Faioni EM, Franchi F, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Finazzi G, Mannucci PM. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). Blood 1999; 94: 3062-6.
    PubMedSearch in Google Scholar
  • 8 Luddington R, Jackson A, Pannerselvam S, Brown K, Baglin T. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C. Thromb Haemost 2000; 83: 204-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Thorelli E, Kaufman RJ, Dahlbäck B. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V. J Biol Chem 1998; 273: 16140-5.
    CrossrefPubMedSearch in Google Scholar
  • 10 Hoekema L, Nicolaes GAF, Hemker HC, Tans G, Rosing J. Human factor Va1 and Va2: properties in the procoagulant and anticoagulant pathways. Biochem 1997; 36: 3331-5.
    CrossrefPubMedSearch in Google Scholar
  • 11 Nicolaes GA, Villoutreix BO, Dahlbäck B. Partial glycosilation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosilation efficiency by mutagenesis of the consensus sequence for N-linked glycosilation. Biochem 1999; 38: 13584-91.
    CrossrefPubMedSearch in Google Scholar